scholarly journals Polyethylene Glycol makes good vehicle in animal health products

1963 ◽  
Vol 41 (35) ◽  
pp. 18
2003 ◽  
Vol 07 (22) ◽  
pp. 1391-1406

Alliance between AGT Biosciences and Starpharma. First Australian Biotech Company to List on HKSE. Breakthrough in Transdermal Drug Discovery Technology. Acrux Licenses MDTS Technology to Eli Lilly got Animal Health Products. Biota Secures SARS Testing Agreement with US Government Research Agencies. SysArris in Bio Partnering Europe 2003. Shantha Bio to Launch Streptokinase by Year-end. Lupin Receives US FDA Approval to Launch Ceftriaxone. MerLion Pharma Collaborates with Schering-Plough in Drug Discovery Research. Quest Pharmaceutical Sets up Taiwanese Subsidiary. BenQ to Invest in Nanjing's Medical Facilities.


1980 ◽  
Vol 60 (1) ◽  
pp. 169-172 ◽  
Author(s):  
G. M. J. HORTON

Lambs were fed monensin (Rumensin®, monensin sodium, Eli Lilly and Co., Greenfield, Ind.) and a deaminase inhibitor 4,4’-dimethyldiphenyliodonium chloride (SmithKline Animal Health Products, West Chester, Pa.) (DAI) at 33 and 25 mg/kg of diet, respectively. Digestibility and ruminal volatile fatty acids were measured using five yearling lambs per treatment. There were no treatment effects on digestibility. Molar proportions of propionic acid were 93% higher when monensin plus DAI were fed than when lambs were offered the nonmedicated control diet. Feedlot performance was measured using eighty 18-kg crossbred lambs, with two pens of 10 lambs per treatment. Lambs fed DAI consumed 8% less feed than controls, though feed to gain ratio was not affected. Gains and feed efficiency with monensin were 8% and 5% higher (P < 0.05), respectively, than control values, though feed was utilized most efficiently when both monensin and DAI were fed.


2010 ◽  
pp. 17-21
Author(s):  
Tímea Gál ◽  
Gábor Grasselli ◽  
István Komlósi

In Hungary the dairy sector is in a long-term critical period, the stock has been in constant decline. The consumption of milk and dairy products in Hungary is slightly rising compared to the world tendency, and it is fallen behind the level in 1990. The milk consumption per capita in 2006 was with 75 liters less than the EU-15 average. Dairy enterprise is a very risky activity: the profitability of the enterprise is affected by the fluctuation of feed and animal health products prices from the side of inputs, and by the fluctuation of end-product prices. Under these circumstances it is vital for thecattle breeders, in order to survive, to harness the reserves in the breeding as effectively as possible. In our research we made a multi-faceted efficiency analysis of an agricultural holding’s three dairy farms. The chosen method for the analysis was Data Envelopment Analysis (DEA). Theselection of the method is justified by the fact that there is not such a reliable database by which we could define production functions, and that DEA makes possible to manage several inputs and outputs, i.e. multiple decision problems, simultaneously. By using DEA the sources that causes shortfalls can be identified, analyzed and quantified on farms that does not operate efficiently, thus it can help the corporate decision support successfully. In the model inputs are the cost data per one liter milk – feed, medicinal product use, logistic costs -, and the main parametersconcerning the keeping and rearing. Outputs are indicators concerning milk production, milk quality and others. We prepared the model in MS Excel, the linear programming model series were programmed by Visual Basic. After solving the model, in light of the shadow prices we can determine why either of the farms is not efficient.


Author(s):  
Patricia Frank ◽  
James Schafer

Sign in / Sign up

Export Citation Format

Share Document